Advertisement

Topics

Companies Related to "Novartis Canakinumab ACZ885 Reduced Cardiovascular Risk Subgroup CANTOS" [Most Relevant Company Matches] RSS

10:46 EDT 20th September 2018 | BioPortfolio

Here are the most relevant search results for "Novartis Canakinumab ACZ885 Reduced Cardiovascular Risk Subgroup CANTOS" found in our extensive corporate database of over 50,000 company records.

Showing "Novartis Canakinumab ACZ885 Reduced Cardiovascular Risk Subgroup CANTOS" Companies 1–25 of 1,800+

Relevant

Pivotal Therapeutics Inc.

With offices in Toronto, Canada and Boca Raton, Florida, Pivotal Therapeutics is a publicly traded (OTCQX: PVTTF; CNSX: PVO) specialty pharmaceutical company with a focus on cardiovascular and overall health. Pivotal Therapeutics' lead product VASCAZENTM is a prescription only medical food formulated to meet the dietary Omega-3 deficient needs of patients ...


Synvista Therapeutics, Inc.

Synvista Therapeutics is a biopharmaceutical company developing drugs to treat and prevent cardiovascular disease and nephropathy in people with diabetes. The Company believes it has identified several product candidates that represent novel approaches to some of the largest pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione pero...

Novartis Consumer Health

Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in each of these areas. In ...


Reprieve Cardiovascular

Reprieve Cardiovascular’s Guided Diuretic Therapy is designed to manage fluids during diuretic therapy for patients with Acute Decompensated Heart Failure (ADHF), and may relieve a number of symptoms related to this condition. The therapy has the potential to enable precise and predictable management of a patient’s fluid levels, guarding against ...

Myogen, Inc.

Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders. We believe that our advanced understanding of the biology of cardiovascular disease combined with our clinical development expertise in cardiovascular therapeutics provide us with the capability to discover novel therapies, ...

Novartis Pharmaceuticals Corporation (NPC), a US subsidiary of Novartis AG

The Lipoprotein(a) Foundation

Because approximately 63 million Americans have high Lipoprotein(a) and are at risk of premature cardiovascular disease, the vision for the foundation is: To live in a world where high Lipoprotein(a) is routinely diagnosed, treated and family screened. The mission is to prevent cardiovascular events due to high Lipoprotein(a) by diagnosing this inherited r...

Novartis AG

Novartis's name, derived from the Latin novae artes, means "new skills" and reflects Novartis's commitment to focus research and development to bring new healthcare products to the patients and physicians. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, pr...

DiagnOptics BV

DiagnOptics is an innovative medical device company based in The Netherlands. The company developed the AGE Reader technology based on findings of scientists and physicians of the Groningen University. We envision DiagnOptics as the world leader in fluorescence-based non-invasive assessment of cardiovascular risk.DiagnOptics developed the AGE Reader, a medical device to estimate cardiovascular ris...

Novartis Vaccines and Diagnostics

Novartis Vaccines is a global leader in providing vaccines to protect against deadly meningococcal disease. Through industry-leading scientific expertise, the company is focused on extending critical meningococcal vaccines research. In addition to developing Menveo vaccine, Novartis Vaccines is developing a recombinant vaccine for its potential to provide broad coverage against multiple strains of...

Cardiovascular Consultants, Ltd.

Cardiovascular Consultants, Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate cardiovascular care to achieve quality of life. Today Cardiovascular Consultants has 38 physicians and 15 mid-level providers in 17 locations, and is one of the largest cardiovasc...

Cardiovascular Consultants Ltd.

Cardiovascular Consultants Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate cardiovascular care to achieve quality of life. Today Cardiovascular Consultants has 36 physicians and 14 mid-level providers in 15 locations, and is one of the largest cardiovascu...

Lipoprotein(a) Foundation

Based in San Carlos, California, the Lipoprotein(a) Foundation is a patient-advocacy, 501(c)(3) nonprofit organization. Because approximately 63 million Americans have high lipoprotein(a) and are at risk of premature cardiovascular disease, the vision for the foundation is to live in a world where high Lipoprotein(a) is routinely diagnosed, treated and fam...

CardioNexus Corporation

CardioNexus Corporation is an affiliated company of Panasonic Healthcare dedicated to reducing cardiovascular disease through early detection and prevention. CardioNexus’ flagship product, the CardioHealth® Station, is a new multi-modality initiative to advance cardiovascular health assessment for the prevention of heart attack and stroke. The advanced, ...

Embrella Cardiovascular, Inc.

Embrella Cardiovascular™, Inc., is dedicated to creating a new standard-of-care for cerebral embolic protection during cardiovascular procedures. Embrella's Embolic Deflector®, an aortic embolic protection device which acts as a protective shield to reduce the incidence of embolization to the brain, has been granted CE Mark approval. Embrella is a ...

Coagulation Diagnostics Incorporated

Coagulation Diagnostics, Inc. (CDI) develops proprietary diagnostic tests for hypercoagulability, or the tendency to form blood clots. The primary applications for the Company's diagnostic tests include monitoring of novel anticoagulants, assessing the risk of acute myocardial infarction, diagnosing possible reactivation of ischemia, and assessing the risk of clotting following invasive cardiovasc...

Speedel

Speedel is a biopharmaceutical company that seeks to create value for patients, partners and investors by developing innovative therapies for cardiovascular and metabolic diseases. Speedel is a world leader in renin inhibition, a promising new approach with significant potential for treating cardiovascular diseases. Our lead product candidate SPP100 (Aliskiren), the first-in-class renin inhibitor,...

Idenix Pharmaceuticals

Idenix is pursuing a disciplined business strategy that seeks to capitalize upon the diverse expertise of the company’s management team. While Idenix is focused on bringing its late-stage product candidates to market, it also believes that maintaining a full pipeline of drug candidates with the potential to become first- or best-in-class therapies for large and growing markets is critical to its...

Premier, Inc

Premier members demonstrate every day that high quality hospitals can be cost-effective. We offer solutions in three areas where quality and financial performance are intimately linked: The healthcare supply chain; performance measurement and improvement; and insurance and risk management. Through Premier's solutions and knowledge-sharing across the alliance, members and clients benefit from:Lower...

Aviir Inc.

Aviir was founded in 2005 by cardiologists and scientists from the Stanford University School of Medicine to focus on discovery, development and commercialization of innovative diagnostic tests. The biotechnology company specializes in developing proprietary diagnostic tests that will assist in identifying patients that are truly at high risk for the...

Pervasis Therapeutics, Inc.

More than eight million Americans over the age of 50 have peripheral arterial disease (PAD), a serious condition in which plaque builds up in arteries, restricting blood flow. PAD has significant health implications, including high blood pressure, reduced ability to walk, leg pain, and increased risk for heart attack and stroke.

RMi

RMi, headquartered in Des Moines, Iowa and with offices in New York City and Thousand Oaks, Calif., is a multi-channel marketing consultancy focused on the pharmaceutical and biotechnology industries. Since 2006, it has worked in more than 30 therapeutic classes, including anti-infectives, allergy, cardiovascular, oncology, infused products and vaccines. A...

The Risk Authority Stanford

The Risk Authority Stanford (TRA Stanford) is a healthcare risk management consulting firm dedicated to transforming its clients’ risk management practices with cutting-edge solutions, unrivaled expertise, and quantifiable results. TRA Stanford’s origins are rooted within the Stanford University Medical Network, and it continues to provide all ...

Aviir, Inc.

Founded in 2005 by cardiologists and researchers from the Stanford University School of Medicine , Aviir is focused on the discovery, development and commercialization of innovative diagnostic and predictive cardiovascular tests, employing state of the art laboratory diagnostic methods. Aviir’s CLIA laboratory in Irvine, CA offers a range of tests for...

Cardiovascular Consultants

Cardiovascular Consultants is a medical practice that specializes exclusively in the diagnosis, treatment, prevention and management of cardiovascular diseases and conditions. What makes us different is our approach to your care.


More From BioPortfolio on "Novartis Canakinumab ACZ885 Reduced Cardiovascular Risk Subgroup CANTOS"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks